ATE427362T1 - Polymorphe marker des lsr-gens - Google Patents

Polymorphe marker des lsr-gens

Info

Publication number
ATE427362T1
ATE427362T1 AT00903924T AT00903924T ATE427362T1 AT E427362 T1 ATE427362 T1 AT E427362T1 AT 00903924 T AT00903924 T AT 00903924T AT 00903924 T AT00903924 T AT 00903924T AT E427362 T1 ATE427362 T1 AT E427362T1
Authority
AT
Austria
Prior art keywords
markers
lsr
biallelic
polymorphoic
phenotype
Prior art date
Application number
AT00903924T
Other languages
English (en)
Inventor
Marta Blumenfeld
Lydie Bougueleret
Bernard Bihain
Original Assignee
Serono Genetics Inst Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Genetics Inst Sa filed Critical Serono Genetics Inst Sa
Application granted granted Critical
Publication of ATE427362T1 publication Critical patent/ATE427362T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00903924T 1999-02-10 2000-02-08 Polymorphe marker des lsr-gens ATE427362T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11959299P 1999-02-10 1999-02-10
US14478499P 1999-07-20 1999-07-20

Publications (1)

Publication Number Publication Date
ATE427362T1 true ATE427362T1 (de) 2009-04-15

Family

ID=26817489

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00903924T ATE427362T1 (de) 1999-02-10 2000-02-08 Polymorphe marker des lsr-gens

Country Status (8)

Country Link
US (2) US6479238B1 (de)
EP (1) EP1153139B1 (de)
AT (1) ATE427362T1 (de)
AU (1) AU767378B2 (de)
CA (1) CA2359757A1 (de)
DE (1) DE60041912D1 (de)
ES (1) ES2323445T3 (de)
WO (1) WO2000047772A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1339869A2 (de) * 2000-07-18 2003-09-03 Serono Genetics Institute S.A. Biallelische marker karten für fettsucht
US20040210400A1 (en) * 2003-01-27 2004-10-21 Perlegen Sciences, Inc. Analysis methods for individual genotyping
US20050019787A1 (en) * 2003-04-03 2005-01-27 Perlegen Sciences, Inc., A Delaware Corporation Apparatus and methods for analyzing and characterizing nucleic acid sequences
WO2005027719A2 (en) * 2003-09-12 2005-03-31 Perlegen Sciences, Inc. Methods and systems for identifying predisposition to the placebo effect
JP2006288220A (ja) * 2005-04-06 2006-10-26 Hitachi High-Technologies Corp 血液検査方法、核酸回収方法、及び、核酸回収器具
WO2007038670A2 (en) * 2005-09-30 2007-04-05 Perlegen Sciences, Inc. Methods and compositions for screening and treatment of disorders of blood glucose regulation
WO2007047913A2 (en) * 2005-10-20 2007-04-26 Isis Pharmaceuticals, Inc Compositions and methods for modulation of lmna expression
WO2008060400A2 (en) * 2006-11-15 2008-05-22 Sirtris Pharmaceuticals, Inc. Sirtuin polymorphisms and methods of use thereof
WO2009126352A2 (en) * 2008-01-24 2009-10-15 Sandia National Laboratories Novel micropores and methods of making and using thereof
CA2830923A1 (en) * 2011-04-15 2012-10-18 Compugen Ltd. Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancer
USD748101S1 (en) * 2013-02-22 2016-01-26 Samsung Electronics Co., Ltd. Graphic user interface for a display screen or a portion thereof
USD745530S1 (en) * 2013-02-22 2015-12-15 Samsung Electronics Co., Ltd. Graphic user interface for a display screen or a portion thereof
CN113136439B (zh) * 2021-05-28 2022-04-08 兰州大学 一种检测绵羊lipe基因单核苷酸多态性的方法及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270170A (en) 1991-10-16 1993-12-14 Affymax Technologies N.V. Peptide library and screening method
US6140466A (en) 1994-01-18 2000-10-31 The Scripps Research Institute Zinc finger protein derivatives and methods therefor
US5691447A (en) 1995-03-24 1997-11-25 Tanox Biosystems, Inc. GC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies
FR2733762B1 (fr) 1995-05-02 1997-08-01 Genset Sa Methode de couplage specifique de la coiffe de l'extremite 5' d'un fragment d'arnm et preparation d'arnm et d'adnc complet
US5869330A (en) 1995-06-05 1999-02-09 Whitehead Institute For Biomedical Research DNA encoding a novel serum protein produced exclusively in adipocytes
DK0892849T3 (da) 1996-01-23 2006-07-24 Indevus Pharmaceuticals Inc Fremgangsmåde til anvendelse af obese-genet og dets genprodukt til stimulering af hæmatopoietisk udvikling
ES2102971B1 (es) 1996-01-25 1998-03-01 Hipra Lab Sa Nueva cepa atenuada del virus causante del sindrome respiratorio y reproductivo porcino (prrs), las vacunas y medios de diagnostico obtenibles con la misma y los procedimientos para su obtencion.
US6116126A (en) 1996-07-10 2000-09-12 Van Den Bulcke; Marc Method and machine for making profile pieces
EP0941366A2 (de) 1996-11-06 1999-09-15 Whitehead Institute For Biomedical Research Biallelische marker
FR2767136B1 (fr) * 1997-08-06 2004-08-27 Genset Sa Recepteur complexe lsr, activite, clonage, et applications au diagnostic, a la prevention et/ou au traitement de l'obesite et des risques ou complications associes
EP1019502A2 (de) 1997-08-06 2000-07-19 Regeneron Pharmaceuticals, Inc. Humane waisenrezeptor ntr-1
FR2767135B1 (fr) 1997-08-06 2002-07-12 Genset Sa Recepteur complexe lsr, activite, clonage, et application au diagnostic, a la prevention et/ou au traitement de d'obesite et des risques ou complications associes
DE69834334T2 (de) 1997-08-26 2007-04-26 Zymogenetics, Inc., Seattle Für adipozyten spezifische protein homologe
DE69837678T2 (de) 1997-10-29 2007-12-27 Otsuka Pharmaceutical Co., Ltd. Compositions zur inhibierung der proliferation glatter muskulatur und verfahren zur diagnose von arteriosklerose

Also Published As

Publication number Publication date
WO2000047772A3 (en) 2000-12-07
DE60041912D1 (de) 2009-05-14
ES2323445T3 (es) 2009-07-16
AU767378B2 (en) 2003-11-06
US6479238B1 (en) 2002-11-12
EP1153139B1 (de) 2009-04-01
US7125667B2 (en) 2006-10-24
EP1153139A2 (de) 2001-11-14
WO2000047772A2 (en) 2000-08-17
US20030190636A1 (en) 2003-10-09
AU2567400A (en) 2000-08-29
CA2359757A1 (en) 2000-08-17

Similar Documents

Publication Publication Date Title
ATE197817T1 (de) Prostatakrebs-gen
WO2000047771A3 (en) Biallelic markers derived from genomic regions carrying genes involved in arachidonic acid metabolism
DE60041912D1 (de) Polymorphe marker des lsr-gens
WO2004023092A3 (en) Genetic analysis and authentication
WO1999014375A3 (en) Dna typing by mass spectrometry with polymorphic dna repeat markers
AU2001254794A1 (en) Diagnosis of diseases associated with dna adducts
WO2001000803A3 (en) Apolipoprotein a-iv-related protein: polypeptide, polynucleotide sequences and biallelic markers thereof
Lee et al. Polymorphism in the mitochondrial cytochrome B gene in Koreans: an additional marker for individual identification
WO2004044163A3 (en) Methods for identifying risk of melanoma and treatments thereof
CA2348828A1 (en) Genomic and complete cdna sequences of apm1 and biallelic markers thereof
WO2001066800A3 (en) Human single nucleotide polymorphisms
WO2001051659A3 (en) Biallelic markers derived from genomic regions carrying genes involved in central nervous system disorders
PT1490383E (pt) Métodos e composições para identificar e caracterizar a hepatite c
WO1999054500A3 (en) Biallelic markers for use in constructing a high density disequilibrium map of the human genome
EP1069189A3 (de) Genotypisierung bialleler Marker
ATE408025T1 (de) Biallelische marker die im zusammenhang stehen mit medikamentenmetabolismus beteiligten genen
WO1999050454A3 (en) Coding sequence polymorphisms in vascular pathology genes
Sanchez et al. Duplications of the Y-chromosome specific loci P25 and 92R7 and forensic implications
MY114645A (en) Cytochrome bd type quinol oxidase gene of brevibacterium lactofermentum
WO2000058519A3 (en) Charaterization of single nucleotide polymorphisms in coding regions of human genes
WO2004020675A3 (en) Polymorphism detection among homologous sequences
WO2002006525A3 (en) Obesity associated biallelic marker maps
MXPA04004291A (es) Polimorfismos de un unico nucleotido en la gh-1.
WO2003023063A1 (fr) Methode d'estimation du risque d'apparition de diabetes
WO2001034840A3 (en) Genetic compositions and methods

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties